Caplin Steriles operates as a subsidiary of the rapidly expanding pharmaceutical firm Caplin Point Laboratories Ltd, specializing in serving Regulated Markets for Injectables and Ophthalmics. Caplin Steriles limited boasts an advanced Research and Development (R&D) facility dedicated to the formulation and analysis of various categories of injectables and ophthalmic dosage forms. The team is comprised of knowledgeable scientists with expertise in Novel drug delivery systems.